Companies · Software / Tech
IRVINE · Software / Tech · refined from filed group “Other Health Care”
Diligence memoA one-page analyst read on JenaValve Technology Inc — recommendation, valuation, rhythm, risks.→JenaValve Technology Inc looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
JenaValve Technology Inc is one of 3920 Software / Tech companies tracked from IRVINE. By capital raised it ranks among the largest (ahead of 99% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.
Round size and date are reported; the stage label is inferred from round size (latest is Series D+ — a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.
Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 99% of sector peers (real $). Modeled value above 98% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #32 of 34.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Mango Technologies, Inc. | Series D+ | $532.4M | $9.1B | 2.74× |
| Cloud Guru Group Inc. | Series D+ | $257.5M | $8.1B | 2.47× |
| Alternative Platform LLC | Series D+ | $250.0M | $7.9B | 2.38× |
| Astranis Space Technologies Corp. | Series D+ | $376.3M | $7.4B | 2.25× |
| Badger Technology Co Holdings Ltd | Series D+ | $254.3M | $6.5B | 1.97× |
| Economic Transformation Technologies Corp | Series D+ | $203.7M | $6.3B | 1.91× |
| Apeel Technology, Inc. | Series D+ | $534.6M | $6.1B | 1.84× |
| Notion Labs, Inc. | Series D+ | $327.0M | $6.0B | 1.82× |
| Hyperloop Technologies, Inc. | Series D+ | $299.9M | $5.4B | 1.65× |
| Onestream Software Llc | Series D+ | $200.0M | $5.2B | 1.58× |
| Verint Systems Inc | Series D+ | $400.0M | $5.2B | 1.58× |
| Luminar Technologies, Inc. | Series D+ | $257.3M | $5.2B | 1.57× |
| JenaValve Technology Inc this company | Series D+ | $328.5M | $2.2B | 0.66× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $13.5M | 2010-03-01 | $61.5M | $375.4M | 85% |
| Series C | $62.5M | 2013-07-19 | $416.7M | $2.0B | 85% |
| Series C | $73.4M | 2013-07-19 | $489.2M | $2.3B | 85% |
| Series C | $26.5M | 2015-07-23 | $176.7M | $832.9M | 85% |
| Series C | $10.0M | 2016-07-29 | $66.7M | $314.2M | 85% |
| Series C | $9.4M | 2017-07-20 | $62.6M | $295.2M | 90% |
| Series C | $14.3M | 2018-01-23 | $95.6M | $450.5M | 90% |
| Series A | $4.9M | 2018-01-23 | $22.3M | $135.8M | 90% |
| Series C | $14.5M | 2019-06-06 | $96.6M | $455.5M | 90% |
| Series C | $66.5M | 2020-01-31 | $443.3M | $2.1B | 90% |
| Series B | $35.5M | 2020-01-31 | $197.2M | $1.1B | 90% |
| Series D+ | $100.4M | 2021-12-21 | $836.7M | $2.2B | 90% |
| Series A | $8.0M | 2021-12-21 | $36.4M | $122.4M | 90% |
| Series C | $73.9M | 2021-12-21 | $492.5M | $1.5B | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Peter Barrett | — | 17 other | 2013-07 |
| Robert Mitchell | — | 8 other | 2017-07 |
| Andrew Hack | — | 4 other | 2020-01 |
| Quan Zhou | — | 4 other | 2018-01 |
| Jan Pensaert | — | 2 other | 2016-07 |
| Kenneth MacLeod | — | 2 other | 2021-12 |
| Rudi Marien | — | 2 other | 2018-01 |
| Daniel Dearen | — | 1 other | 2021-12 |
| John Kilcoyne | — | 1 other | 2019-06 |
| Jose Calle Gordo | — | 1 other | 2019-06 |
| Keith Dawkins | — | 1 other | 2018-01 |
| Olivier Litzka | — | 1 other | 2010-03 |
| Ouyang Xiangyu | — | 1 other | 2013-07 |
| Peter Wulff | — | 1 other | 2016-07 |
| Raymond Cohen | — | 1 other | 2013-07 |
| Regina Hodits | — | 1 other | 2010-03 |
| Victoria Carr-Brendel | — | 1 other | 2015-07 |
| Arnd Christian Kaltofen | — | — | 2010-03 |
| Arnd Kaltofen | — | — | 2013-07 |
| Carl Christian Gilhuus-Moe | — | — | 2010-03 |
| David Drachman | — | — | 2013-07 |
| Erik Amble | — | — | 2013-07 |
| Hans-Reiner Figulla | — | — | 2013-07 |
| Helmut Straubinger | — | — | 2010-03 |
JenaValve Technology Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Elise A.I. Technologies Corp. | Software / Tech | Series D+ | $320.9M | $1.8B | same sector · same stage |
| PureCycle Technologies, Inc. | Software / Tech | Series D+ | $340.0M | $984.4M | same sector · same stage |
| Altana Technologies, Inc. | Software / Tech | Series D+ | $344.1M | $2.5B | same sector · same stage |
| Sentinel Labs, Inc. | Software / Tech | Series D+ | $345.5M | $2.8B | same sector · same stage |
| Fever Labs, Inc. | Software / Tech | Series D+ | $347.2M | $1.1B | same sector · same stage |
| Figure Technologies, Inc. | Software / Tech | Series D+ | $299.9M | $2.9B | same sector · same stage |
| Huntress Labs Inc | Software / Tech | Series D+ | $292.1M | $2.1B | same sector · same stage |
| Span.IO, Inc. | Software / Tech | Series D+ | $384.1M | $1.3B | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| CareSave Technologies, Inc. | Software / Tech | Series C | $28.8M | 82% |
| Soovu Labs, Inc. | Software / Tech | Seed | $4.3M | 82% |
| Rovex Technologies Corp | Software / Tech | Pre-Seed | $2.8M | 81% |
| Transradial Technologies, Inc. | Software / Tech | Pre-Seed | $1.4M | 81% |
| Medici Technologies, LLC | Software / Tech | Series B | $618.6M | 81% |
| MediCool Technologies, Inc. | Software / Tech | Pre-Seed | $26.1M | 81% |
| Surgicure Technologies, Inc. | Software / Tech | Seed | $11.0M | 81% |
| Applikate Technologies, Inc. | Software / Tech | Seed | $51.9M | 81% |
See where JenaValve Technology Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at JenaValve Technology Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.